BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $316,000 | -97.8% | 25,977 | -95.6% | 0.00% | -100.0% |
Q1 2021 | $14,472,000 | -60.9% | 596,546 | -48.3% | 0.00% | -57.1% |
Q4 2020 | $36,979,000 | +8.3% | 1,153,828 | +2.2% | 0.01% | 0.0% |
Q3 2020 | $34,138,000 | -39.6% | 1,129,292 | -16.0% | 0.01% | -46.2% |
Q2 2020 | $56,477,000 | +81.6% | 1,343,797 | +6.2% | 0.01% | +62.5% |
Q1 2020 | $31,101,000 | – | 1,264,898 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |